THE RATIO OF LIPIDPEROXIDES TO SUPEROXIDE-DISMUTASE ACTIVITY IN THE SKIN-LESIONS OF PATIENTS WITH SEVERE SKIN DISEASES - AN ACCURATE PROGNOSTIC INDICATOR

被引：55

作者：

NIWA, Y

KANOH, T

SAKANE, T

SOH, H

KAWAI, S

MIYACHI, Y

机构：

[1] SHIMANE MED UNIV,DEPT INTERNAL MED,IZUMO,SHIMANE 693,JAPAN

[2] KYOTO UNIV,DEPT INTERNAL MED,KYOTO 606,JAPAN

[3] KANSAI MED UNIV,DEPT DERMATOL,MORIGUCHI,OSAKA 570,JAPAN

[4] KYOTO UNIV,DEPT DERMATOL,KYOTO 606,JAPAN

来源：

LIFE SCIENCES | 1987年 / 40卷 / 10期

关键词：

D O I：

10.1016/0024-3205(87)90310-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：921 / 927

页数：7

共 27 条

[1] ASSAY AND INHIBITORS OF SPINACH SUPEROXIDE-DISMUTASE [J].

ASADA, K ;

TAKAHASHI, M ;

NAGATE, M .

AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1974, 38 (02) :471-473

[2] INDUCTION OF SUPEROXIDE DISMUTASE BY MOLECULAR-OXYGEN [J].

GREGORY, EM ;

FIRDOVIC.I .

JOURNAL OF BACTERIOLOGY, 1973, 114 (02) :543-548

[3]

ICHIHARA K, 1977, J BIOCHEM, V81, P1427

[4] SUPEROXIDE-DISMUTASE FROM MYCOBACTERIUM SPECIES, STRAIN TAKEO [J].

KUSUNOSE, M ;

NODA, Y ;

ICHIHARA, K ;

KUSUNOSE, E .

ARCHIVES OF MICROBIOLOGY, 1976, 108 (01) :65-73

[5]

MASUGI F, 1977, VITAMINS, V51, P21

[6] EFFECTS OF PSORIATIC SERA ON THE GENERATION OF OXYGEN INTERMEDIATES BY NORMAL POLYMORPHONUCLEAR LEUKOCYTES [J].

MIYACHI, Y ;

NIWA, Y .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1983, 275 (01) :23-26

[7] AUTO-OXIDATIVE DAMAGE IN CEMENT DERMATITIS [J].

MIYACHI, Y ;

UCHIDA, K ;

KOMURA, J ;

ASADA, Y ;

NIWA, Y .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1985, 277 (04) :288-292

[8] EFFECT OF THERMAL-INJURY ON LIPID PEROXIDE LEVELS OF RAT [J].

NISHIGAKI, I ;

HAGIHARA, M ;

HIRAMATSU, M ;

IZAWA, Y ;

YAGI, K .

BIOCHEMICAL MEDICINE, 1980, 24 (02) :185-189

[9] OXYGEN-METABOLISM IN PHAGOCYTES OF LEPROTIC PATIENTS - ENHANCED ENDOGENOUS SUPEROXIDE-DISMUTASE ACTIVITY AND HYDROXYL RADICAL GENERATION BY CLOFAZIMINE [J].

NIWA, Y ;

SAKANE, T ;

MIYACHI, Y ;

OZAKI, M .

JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (05) :837-842

[10]

NIWA Y, 1982, CLIN EXP IMMUNOL, V49, P247

← 1 2 3 →